Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry

European Respiratory Journal

Volumn 42, Issue 4, 2013, Pages 1046-1054

  Quanjer, Philip H ^a   Brazzale, Danny J ^b   Boros, Piotr W ^c   Pretto, Jeffrey J ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Austin Hospital   (Germany)

^c NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^d JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REFERENCE VALUE; RETROSPECTIVE STUDY; SPIROMETRY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; AUSTRALIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; NUTRITION SURVEYS; POLAND; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; REFERENCE STANDARDS; REFERENCE VALUES; RETROSPECTIVE STUDIES; SPIROMETRY; YOUNG ADULT;

EID: 84883200814     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00195512     Document Type: Article

References (39)

1. Quanjer PH. Standardized lung function testing. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Bull Eur Physiopath Respir 1983; 19: Suppl. 5, 45-51.
2. Quanjer PH, Stocks J, Polgar G, et al. Compilation of reference values for lung function measurements in children. Eur Respir J 1989; 2: Suppl. 4, 184S-261S.
3. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
4. Sood A, Dawson BK, Henkle JQ, et al. Effect of change of reference standards to NHANES III on interpretation of spirometric "abnormality" . Int J Chron Obstruct Pulm Dis 2007; 2: 361-367.
5. Collen J, Greenburg D, Holley A, et al. Discordance in spirometric interpretations using three commonly used reference equations vs National Health and Nutrition Examination Study III. Chest 2008; 134: 1009-1016.
6. Brazzale DJ, Upward AL, Pretto JJ. Effects of changing reference values and definition of the normal range on interpretation of spirometry. Respirology 2010; 15: 1098-1103.
7. Quanjer PH, Hall GL, Stanojevic S, et al. Age- and height-based prediction bias in spirometry reference equations. Eur Respir J 2012; 40: 190-197.
8. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med 2008; 177: 253-260.
9. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
10. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5S-40S.
11. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
12. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease. www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html Date last accessed: September 29, 2011. Date last updated: February 2013.
13. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
14. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
15. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98.
16. Bridevaux PO, Gerbase MW, Probst-Hensch NM, et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008; 63: 768-774.
17. Vaz Fragoso CA, Concato J, McAvay G, et al. Chronic obstructive pulmonary disease in older persons: a comparison of two spirometric definitions. Respir Med 2010; 104: 1189-1196.
18. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 446-451.
19. Pedone C, Scarlata S, Sorino C, et al. Does mild COPD affect prognosis in the elderly?BMC Pulm Med 2010; 10: 35.
20. Vaz Fragoso CA, Gill TM, McAvay G, et al. Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged persons. Respir Care 2011; 56: 1771-1777.
21. Miller MR, Quanjer PH, Swanney MP, et al. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest 2011; 139: 52-59.
22. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991; 144: 1202-1218.
23. Sobol BJ. Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility. Thorax 1966; 2: 445-449.
24. Sobol BJ, Sobol PG. Per cent of predicted as the limit of normal in pulmonary function testing: a statistically valid approach. Thorax 1979; 34: 1-3.
25. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988; 43: 265-267.
26. Kirkby J, Aurora P, Spencer H, et al. Stitching and switching: the impact of discontinuous lung function reference equations. Eur Respir J 2012; 39: 1256-1257.
27. Global Lung Function Initiative. GLI 2012 Data Conversion Software. www.lungfunction.org/files/ InstallGLI2012-DataConversion.EXE Date last accessed: March 1, 2013. Date last updated: May 10, 2013.
28. Roca J, Burgos F, Sunyer J, et al. References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J 1998; 11: 1354-1362.
29. Mannino DM, Doherty DE, Buist SA. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100: 115-122.
30. Mannino DM, Buist SA, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007; 62: 237-241.
31. Aaron SD, Dales RE, Cardinal P. How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 1999; 115: 869-873.
32. Glady CA, Aaron SD, Lunau ML, et al. A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory. Chest 2003; 123: 1939-1946.
33. Swanney MP, Beckert LE, Frampton CM, et al. Validity of the American Thoracic Society and other spirometric algorithms using FVC and forced expiratory volume at 6 s for predicting a reduced total lung capacity. Chest 2004; 126: 1861-1866.
34. Boros P, Franczuk M, Wesołowski S. Zmiany "mieszane" - weryfikacja rozpoznania typu zaburzeń wentylacyjnych ["Mixed" changes in spirometry-verification of the pattern of lung function impairment]. Pneumonol Alergol Pol 2003; 71: 527-532.
35. Dykstra BJ, Scanlon PD, Kester MM, et al. Lung volumes in 4774 patients with obstructive lung disease. Chest 1999; 115: 68-74.
36. Boros PW, Franczuk M, Wesolowski S. Value of spirometry in detecting volume restriction in interstitial lung disease patients: spirometry in interstitial lung diseases. Respiration 2004; 71: 374-379.
37. Saunders KB. Clinical Physiology of the Lung. Oxford, Blackwell Science Publications, 1977.
38. Quanjer PH, Stocks J, Cole TJ, et al. Influence of secular trends and sample size on reference equations for lung function tests. Eur Respir J 2011; 37: 658-664.
39. Johannessen A, Lehmann S, Omenaas ER, et al. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006; 173: 1316-1325.